- • Up to 20%-50%* off first purchase
- • Bulk quantities available
- • Citation Reward application
AAV ProDUCTS & SERVICE
AAV TECHNICAL RESOURCE
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
AAV-SIG vector system (AAV-SIG expression system, AAV-SIG packaging plasmid system ) (Amp and Kanamycin) (GeneMedi Owned)
GeneMedi (GM) AAV-SIG Vector system is including: 1) AAV-SIG Rep-Cap plasmid (AAV-SIG-RC plasmid) 2) AAV Helper plasmid 3) AAV expression vectors (overexpression or shRNA).
You can produce AAV-SIG particle in 293T cell line in high titer using GeneMedi's AAV-SIG Rep-Cap plasmid with GM's AAV expression vector (overexpression or shRNA) and AAV helper plasmid.
The tissue tropism of AAV-SIG vector has been validated in endothelium, with potential applications in tissue-specific gene therapy.
GeneMedi offers both Ampicillin (Amp) resistance and Kanamycin (Kan) resistance for the AAV Rep-Cap Plasmids, AAV expression Plasmids and AAV helper Plasmid.
Go to AAV
vector system
>>
Map Download
Product Description
| Cat.NO | Product Name | Organization Type | Price(In USD) | First Order Discount | First Order Discount Price |
|---|---|---|---|---|---|
| P-PK25 | AAV-SIG Vector System (Amp resistance) 1. AAV-SIG Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | Academic | 3379 | 50% | 1689.5 |
| P-PK25 | AAV-SIG Vector System (Amp resistance) 1. AAV-SIG Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | Biotech & Pharma & Medical Device & Diagnostics | 50% | ||
| P-PK25 | AAV-SIG Vector System (Amp resistance) 1. AAV-SIG Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | CRO&CDMO& CXO&CMC& Manufacturing company |
50% | ||
| P-PK25 | AAV-SIG Vector System (Amp resistance) 1. AAV-SIG Rep-Cap Plasmid, ≥10mg 2. AAV Helper Plasmid, ≥10mg 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01-Kan), ≥10mg |
All | |||
| P-PK25-Kan | AAV-SIG Vector System (Kan resistance) 1. AAV-SIG Rep-Cap Plasmid (Kan resistance) , ≥10mg 2. AAV Helper Plasmid (Kan resistance) , ≥10mg 3. pGMAAV-CMV-MCS-T2A-ZsGreen (Kan resistance) (P-AAVV-B01-Kan), ≥10mg |
All | |||
| P-RC25 | AAV-SIG Rep-Cap
Plasmid (Amp resistance)
Size：5ug |
Academic | 2062 | 50% | 1031 |
| P-RC25 | AAV-SIG Rep-Cap
Plasmid (Amp resistance)
Size：5ug | Biotech & Pharma & Medical Device & Diagnostics | 50% | ||
| P-RC25 | AAV-SIG Rep-Cap
Plasmid (Amp resistance)
Size：5ug | CRO&CDMO& CXO&CMC& Manufacturing company |
50% | ||
| P-RC25 | AAV-SIG Rep-Cap
Plasmid (Amp resistance)
Size：≥10mg |
All | |||
| P-RC25-Kan | AAV-SIG Rep-Cap
Plasmid(Kan resistance)
Size：≥10mg |
All | |||
|
GeneMedi offers both seed and amplification services for the Amp-resistant AAV Vector System. GeneMedi only offers amplification services and do not provide seed for the Kan-resistant AAV Vector System currently. |
|||||
| If you want to obtain higher quantities of plasmids (mg), please visit GM TransExcellent Plasmid DNA Rapid Preparation Service. | |||||
|
Terms of sale: For Seed (5ug): The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for any other party. For plasmid production& amplification (≥10mg): The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for themselves or any other party. |
|||||
Citation
| Title | Publication | Date |
|---|---|---|
| Suppression of PFKFB3-driven glycolysis restrains endothelial-to-mesenchymal transition and fibrotic response | Signal Transduction and Targeted Therapy | 2022/9/1 |
| Sja-miR-71a in Schistosome egg-derived extracellular vesicles suppresses liver fibrosis caused by schistosomiasis via targeting semaphorin 4D | Journal of Extracellular Vesicles | 2020/7/9 |
| ACSL4 Promotes Microglia-Mediated Neuroinflammation by Regulating Lipid Metabolism and VGLL4 expression | Brain, Behavior, and Immunity | 2023/2/14 |
| Extracellular fibrinogen-binding protein released by intracellular Staphylococcus aureus suppresses host immunity by targeting TRAF3 | Nature Communications | 2022/9/19 |
| Extracellular Vesicles Derived From Human Dermal Fibroblast Effectively Ameliorate Skin Photoaging via miRNA-22-5p-GDF11 Axis | Chemical Engineering Journal | 2022/10/6 |
| Tensile Stress‐Activated and Exosome‐Transferred YAP/TAZ‐Notch Circuit Specifies Type H Endothelial Cell for Segmental Bone Regeneration | Advanced Science | 2024/1/15 |
| Impeding the combination of astrocytic ASCT2 and NLRP3 by talniflumate alleviates neuroinflammation in experimental models of Parkinson's disease | Acta Pharmaceutica Sinica B | 2022/8/3 |
| Runx1 protects against the pathological progression of osteoarthritis | Bone Research | 2021/12/7 |
| Pre-ischemia melatonin treatment alleviated acute neuronal injury after ischemic stroke by inhibiting ER stress-dependent autophagy via PERK and IRE1 signalings | JOURNAL OF PINEAL RESEARCH | 2017/5/6 |
| TRPV1 SUMOylation regulates nociceptive signaling in models of inflammatory pain | Nature Communications | 2018/4/18 |
Validation data
No data found
Associated products and services
| Products & Service | Products & Service Information |
|---|---|
| AAV Packaging service | Detail |
| Promise-ORF™ viral CDNA library | Detail |
| Plasmid DNA Rapid Preparation Service | Detail |
Facebook
LinkedIn
Twitter
